Cronos (CRON) Change in Accured Expenses (2020 - 2026)
Cronos (CRON) recorded quarterly Change in Accured Expenses of -$5.1 million in Q1 2026, down 183.32% quarter-over-quarter from $6.2 million in Q4 2025, and up 42.12% on a YoY basis from -$3.6 million in Q1 2025.
Cronos (CRON) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Cronos' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$5.1 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 42.12% year-over-year to -$5.1 million; the TTM figure through Mar 2026 stood at $6.2 million (up 732.89% YoY), while the FY2025 annual figure was $2.4 million, down 14.15% from the prior year.
- Change in Accured Expenses was -$5.1 million for Q1 2026 at Cronos, down from $6.2 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $7.7 million in Q3 2023 to a low of -$8.9 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged $139882.4 across 5 years, with a median of $1.4 million in 2022.
- Biggest YoY gain for Change in Accured Expenses was 436.92% in 2023; the steepest drop was 150.6% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at -$2.8 million in 2022, then jumped by 214.8% to $3.2 million in 2023, then sank by 62.86% to $1.2 million in 2024, then jumped by 411.02% to $6.2 million in 2025, then sank by 183.32% to -$5.1 million in 2026.
- The last three Change in Accured Expenses figures came in at -$5.1 million (Q1 2026), $6.2 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Cronos | 1.06 Bn | 292.44 Mn | 19.15 Mn | -5.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.14 Mn |
| Mar 31, 2026 | -5.14 Mn |
| Dec 31, 2025 | 6.17 Mn |
| Dec 31, 2025 | 6.17 Mn |
| Sep 30, 2025 | 4.28 Mn |
| Sep 30, 2025 | 4.28 Mn |
| Jun 30, 2025 | 865,000.00 |
| Jun 30, 2025 | 865,000.00 |
| Mar 31, 2025 | -8.88 Mn |
| Mar 31, 2025 | -8.88 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Jun 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 1.75 Mn |
| Mar 31, 2024 | -5.06 Mn |
| Mar 31, 2024 | -5.06 Mn |
| Dec 31, 2023 | 3.25 Mn |
| Dec 31, 2023 | 3.25 Mn |